Creatine phosphokinase activity and clinical symptomatology. A study in acute schizophrenic patients.
作者信息
Meltzer H Y
出版信息
Arch Gen Psychiatry. 1973 Nov;29(5):589-93. doi: 10.1001/archpsyc.1973.04200050005001.
Abstract
摘要
相似文献
1
Creatine phosphokinase activity and clinical symptomatology. A study in acute schizophrenic patients.
Arch Gen Psychiatry. 1973 Nov;29(5):589-93. doi: 10.1001/archpsyc.1973.04200050005001.
2
Serum creatine phosphokinase and aldolase activity in acute schizophrenic patients and their relatives.
Compr Psychiatry. 1970 Nov;11(6):552-8.
3
[Behavior of serum CPK (creatine phosphokinase) and aldolase levels in psychiatric patients].
Acta Neurol (Napoli). 1972 Jul-Aug;27(4):386-94.
4
Serum creatine kinase, aldolase, and copper in acute and chronic schizophrenics.
Biol Psychiatry. 1970 Oct;2(4):331-9.
5
A study of thought disorder in paranoid and non-paranoid schizophrenia.
Psychopathology. 1991;24(3):166-9. doi: 10.1159/000284710.
6
Paranoid schizophrenia in adolescence.
J Clin Psychiatry. 1991 Sep;52(9):365-8.
7
Muscle abnormalities in acute psychoses.
Arch Gen Psychiatry. 1970 Dec;23(6):481-91. doi: 10.1001/archpsyc.1970.01750060001001.
8
Clinical subtypes and age at onset in schizophrenic siblings.
Psychiatry Res. 1992 Feb;41(2):107-14. doi: 10.1016/0165-1781(92)90103-a.
9
The failure of the schizophrenia concept and the argument for its replacement by hebephrenia: applying the medical model for disease recognition.
Acta Psychiatr Scand. 2010 Sep;122(3):173-83. doi: 10.1111/j.1600-0447.2010.01589.x.
10
Creatine phosphokinase activity in newly admitted psychiatric patients.
Br J Psychiatry. 1972 Oct;121(563):351-5. doi: 10.1192/bjp.121.4.351.
引用本文的文献
1
Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?
Neurosci Biobehav Rev. 2012 May;36(5):1442-62. doi: 10.1016/j.neubiorev.2012.03.005. Epub 2012 Mar 24.
Zotero 插件